Tirzepatide 30mg
High-concentration format of the dual GIP/GLP-1 co-agonist for extended assay series.
$100 minimum order. Free shipping over $300, otherwise $20. US domestic only. Zelle orders get an extra 5% off at checkout.
About this compound
Identical molecular structure to the 10mg format. The 30mg vial is intended for research programs requiring larger reconstitution volumes, concentration-response curves across wide dose ranges, or extended assay series without the need for multiple vials. High-throughput screening, multi-dose concentration studies, batch assay work requiring consistent compound across large experimental series.
| CAS | 2023788-19-2 |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Storage | −20°C, protect from light |
| Fill | 30mg per vial |
| Form | Lyophilized powder |
| Lab results | 23 on file · latest 17 Aug 2026 |
Certificates of analysis
Results come from Janoshik Analytical Laboratory, an independent lab. Open any result to see the full report, or look up the test ID at janoshik.com.
| Date | Test | Batch | Test ID | Link |
|---|---|---|---|---|
| 17 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #221496 | View result |
| 17 Aug 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #221495 | View result |
| 17 Aug 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #212716 | View result |
| 17 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #195958 | View result |
| 1 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #206905 | View result |
| 1 Aug 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #206900 | View result |
| 1 Aug 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #206897 | View result |
| 1 Aug 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #206892 | View result |
| 8 Jul 2026 | TirzepatideIdentity & purity · Janoshik Analytical Laboratory | – | #195957 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #195388 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #195387 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #195376 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #195375 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #194262 | View result |
| 8 Jul 2026 | Tirzepatide 60mgIdentity & purity · Janoshik Analytical Laboratory | – | #193636 | View result |
| 8 Jul 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #193635 | View result |
| 8 Jul 2026 | Tirzepatide 30mgIdentity & purity · Janoshik Analytical Laboratory | – | #193629 | View result |
| 8 Jul 2026 | TirzepatideEndotoxin · Janoshik Analytical Laboratory | – | #193628 | View result |
| Apr 2026 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #133565 | View result |
| Mar 2026 | TirzepatideHPLC identity & purity · Janoshik Analytical Laboratory | – | #111319 | View result |
| Nov 2025 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | Batch 5 | #85615 | View result |
| Aug 2025 | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #72922 | View result |
| Prior | Tirzepatide 10mgHPLC identity & purity · Janoshik Analytical Laboratory | – | #44778 | View result |
Results are from our supplier's published testing records. Dates show when each result was published. Each test covers the sample sent to the lab. See every compound on the lab results page.
More research compounds
Semaglutide
Long-acting GLP-1 receptor agonist analog for pancreatic β-cell signaling and incretin axis research.
Tirzepatide 10mg
Dual GIP/GLP-1 receptor co-agonist for comparative receptor selectivity and metabolic pathway research.
Retatrutide 10mg
Triple GLP-1/GIP/GCG receptor agonist for incretin crosstalk and glucagon pathway research.
Retatrutide 30mg
High-concentration triple GLP-1/GIP/GCG agonist for extended research series and multi-dose protocols.
For in vitro research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. By ordering you agree to our terms of service and research use agreement.